J. Bosomworth

发表

A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression

G. Tollefson, J. Potvin, J. Heiligenstein, 1995, International Psychogeriatrics.

Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity.

L. Levine, J. Bosomworth, S. Rosenblatt, 1987, International journal of obesity.

Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.

C. Beasley, J. Wernicke, J. Bosomworth, 1990, Psychopharmacology bulletin.

Fluoxetine at 20 mg per day: the recommended and therapeutic dose in the treatment of depression.

J. Wernicke, J. Bosomworth, E. Ashbrook, 1989, International clinical psychopharmacology.

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

C. Beasley, J. Heiligenstein, D. Murphy, 1991, BMJ.

Low-dose fluoxetine therapy for depression.

J. Wernicke, B. Dornseif, J. Bosomworth, 1988, Psychopharmacology bulletin.

Fluoxetine versus trazodone: efficacy and activating-sedating effects.

C. Beasley, B. Dornseif, M. Sayler, 1991, The Journal of clinical psychiatry.

A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group.

G. Tollefson, J. Potvin, J. Heiligenstein, 1995, International psychogeriatrics.

High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.

C. Beasley, J. Wernicke, M. Sayler, 1991, Journal of clinical psychopharmacology.

Fluoxetine and suicide : a meta-analysis of controlled trials of treatment for depression

C. Beasley, J. Heiligenstein, D. Murphy, 1992 .

Efficacy and safety of morning versus evening fluoxetine administration.

C. Beasley, J. Bosomworth, R. W. Usher, 1991, The Journal of clinical psychiatry.

The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam

R. Bergstrom, H. Rowe, L. Lemberger, 1988, Clinical pharmacology and therapeutics.